ArticleDrugs2022

Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence".

Mario Gennaro Mazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.